ZEINA BJEIJEH: Open Payments
NPI 1851083596 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 54 payments from 20 companies in 2025. Trend: 2023 $859 · 2024 $2,077 · 2025 $1,579
Food & beverage: $1,579
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $324 |
| Medtronic, Inc. | 2 | $166 |
| Xeris Pharmaceuticals, Inc. | 8 | $143 |
| Sequel Med Tech, LLC | 1 | $124 |
| Lilly USA, LLC | 7 | $116 |
| Madrigal Pharmaceuticals | 3 | $97 |
| Dexcom, Inc. | 4 | $85 |
| Corcept Therapeutics | 3 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $67 |
| Amgen Inc. | 3 | $64 |
Products named: Ozempic, MINIMED 780G, RECORLEV, TWIIST, REZDIFFRA, Dexcom G6 Transmitter, Korlym, CRENESSITY.
Industry payments across MI — which companies pay providers there.
